novo nordisk wegovy news - Search News

Novo Nordisk shares tumble

Hosted on MSN · 1d

Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down double digits in premarket trading. CagriSema, a drug that Novo Nordisk had hoped would become its next generation weight-loss aid,

New York Post on MSN · 2d

Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results

Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to follow Wegovy in the fiercely competitive anti-obesity market.

Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug CagriSema, wiping as much as $125 billion off its market value.

2don MSN

Novo Nordisk stock just tanked 25%: here’s what happened

Novo Nordisk posts disappointing update related to its new weight loss drug CagriSema. Novo Nordisk stock is now down 25% ...

2d

Novo Nordisk Stock: A Rare Buying Opportunity

Financial writer sees Novo Nordisk's stock drop as a buying opportunity after disappointing trial results, citing strong ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results